Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 3;61(5):695-704.
doi: 10.1016/j.molcel.2016.02.019.

Mitochondria-Judges and Executioners of Cell Death Sentences

Patrick D Bhola  1 , Anthony Letai  2
Affiliations
Review

Mitochondria-Judges and Executioners of Cell Death Sentences

Patrick D Bhola et al. Mol Cell. .

Abstract

Apoptosis is a form of programmed cell death that is critical for basic human development and physiology. One of the more important surprises in cell biology in the last two decades is the extent to which mitochondria represent a physical point of convergence for many apoptosis-inducing signals in mammalian cells. Mitochondria not only adjudicate the decision of whether or not to commit to cell death, but also release toxic proteins culminating in widespread proteolysis, nucleolysis, and cell engulfment. Interactions among BCL-2 family proteins at the mitochondrial outer membrane control the release of these toxic proteins and, by extension, control cellular commitment to apoptosis. This pathway is particularly relevant to cancer treatment, as most cancer chemotherapies trigger mitochondrial-mediated apoptosis. In this Review, we discuss recent advances in the BCL-2 family interactions, their control by upstream factors, and how the mitochondria itself alters these interactions. We also highlight recent clinical insights into mitochondrial-mediated apoptosis and novel cancer therapies that exploit this pathway.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Interactions between the Bcl-2 family of proteins at the mitochondria determines commitment to apoptotic cell death. Physiological or therapeutic apoptotic stimuli alter different classes of Bcl-2 proteins. Activation of effector proteins result in cytochrome c release from mitochondria, and degradation of the cell. (*) Recent evidence indicates that NOXA can also act as an activator BH3 protein.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Molecular cell. 2002;9:423–432. - PubMed
    1. Annis MG, Soucie EL, Dlugosz PJ, Cruz-Aguado JA, Penn LZ, Leber B, Andrews DW. Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. The EMBO journal. 2005;24:2096–2103. - PMC - PubMed
    1. Aouacheria A, Rech de Laval V, Combet C, Hardwick JM. Evolution of Bcl-2 homology motifs: homology versus homoplasy. Trends in cell biology. 2013;23:103–111. - PMC - PubMed
    1. Aranovich A, Liu Q, Collins T, Geng F, Dixit S, Leber B, Andrews DW. Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells. Molecular cell. 2012;45:754–763. - PubMed
    1. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 2005;434:658–662. - PubMed

Publication types

MeSH terms

Substances